Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/20/2013CN103393678A Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
11/20/2013CN103393677A Use of fungicides for treating fish mycoses
11/20/2013CN103393676A Application of auraptene to preparing medicaments for inhibiting enterovirus 71-type infection
11/20/2013CN103393675A Application of Aphanamgrandiol A in preparing monoamine oxidase (MAO) inhibitor
11/20/2013CN103393674A Application of Aphanamgrandiol A in preparing medicines for treating or preventing acute heart failure
11/20/2013CN103393673A Application of compound in anti-aseptic inflammation drug preparation
11/20/2013CN103393672A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
11/20/2013CN103393671A Extracting and refining method of ginkgolide
11/20/2013CN103393670A Application of Chukrasone B in preparing anti-hypoxic medicines
11/20/2013CN103393669A Application of Chukrasone B in medicament for preventing pancreas fibrosis
11/20/2013CN103393668A Application of Sarcaboside B to medicament for treatment of pancreas cancer
11/20/2013CN103393667A Application of Sarcaboside A to medicament for treatment of leukemia
11/20/2013CN103393666A Application of Sarcaboside A to medicament for rising white blood cell
11/20/2013CN103393665A Application of Sarcaboside A to medicament for treatment of renal carcinoma
11/20/2013CN103393664A Application of Sarcaboside A to medicament for resisting aseptic inflammation
11/20/2013CN103393663A Application of Sarcaboside B to anti-hypoxic drug
11/20/2013CN103393662A Application of Sarcaboside B to preparation of hypoglycemic medicament
11/20/2013CN103393661A Application of Sarcaboside A to medicament for treatment or prevention of acute heart failure
11/20/2013CN103393660A Application of Sarcaboside B to preparation of medicament for raising erythrocyte
11/20/2013CN103393659A Application of Sarcaboside B to medicament for prevention of pancreatic fibrosis
11/20/2013CN103393658A Application of Sarcaboside A to medicament for treatment of bladder cancer
11/20/2013CN103393657A Application of Sarcaboside A to medicament for treatment of myocardial ischemia
11/20/2013CN103393656A Application of Sarcaboside A to medicament for resisting lung cancer metastasis
11/20/2013CN103393655A Application of Sarcaboside B to medicament for treatment and prevention of oral ulcer
11/20/2013CN103393654A Application of Sarcaboside A to medicament for treatment of endometrial carcinoma
11/20/2013CN103393653A Application of Sarcaboside B to medicament for treatment of carcinoma of bile duct
11/20/2013CN103393652A Application of Sarcaboside A to medicament for treatment of laryngocarcinoma
11/20/2013CN103393651A Application of Sarcaboside B to preparation of medicament for treatment of chronic obstructive pulmonary disease
11/20/2013CN103393650A Application of Sarcaboside A to medicament for resisting osteoporosis caused by estrogen deficiency
11/20/2013CN103393649A Application of Sarcaboside A to medicament for treatment of rheumatoid osteoarthritis
11/20/2013CN103393648A Application of Sarcaboside A to vasodilator medicament
11/20/2013CN103393647A Application of Sarcaboside B to preparation of medicament for treatment and prevention of renal insufficiency
11/20/2013CN103393646A Application of Sarcaboside A to medicament for treatment of rhinitis
11/20/2013CN103393645A Application of Sarcaboside B to medicament for treatment of skin cancer
11/20/2013CN103393644A Application of Sarcaboside A to preparation of medicament for treatment of ileocecum cancer
11/20/2013CN103393643A Application of Sarcaboside A to monoamine oxidase inhibitor
11/20/2013CN103393642A Application of Sarcaboside A to hypoglycemic medicament
11/20/2013CN103393641A Application of Sarcaboside A to medicament for treatment of atherosclerosis
11/20/2013CN103393640A Application of Sarcaboside B to antidepressant medicament
11/20/2013CN103393639A Medicinal composition for treating lung cancer and preparation method thereof
11/20/2013CN103393638A Application of formononetin in preparing medicine for treating breast cancer
11/20/2013CN103393637A Use of flavonoid compound in preparation of metabolic disease resistance medicines
11/20/2013CN103393636A Application of Nardoaristolones A in preparing medicines for treating lung cancer metastasis
11/20/2013CN103393635A Application of Nardoaristolones A in preparing medicines for treating rheumatoid arthritis
11/20/2013CN103393634A Medicine composition for treating digestive system disease, preparation method and use
11/20/2013CN103393633A Pharmaceutical composition of paclitaxel and ranitidine hydrochloride
11/20/2013CN103393632A Cabazitaxel drug composition and preparation method thereof
11/20/2013CN103393631A Flurbiprofen axetil pharmaceutical composition
11/20/2013CN103393630A Method of inducing terminal differentiation
11/20/2013CN103393629A Novel pharmaceutical use of tamoxifen
11/20/2013CN103393628A Application of muscarinic receptor 3 in treating prostatic cancer
11/20/2013CN103393627A Application of sesquiterpenoids compound on preparation of miticides
11/20/2013CN103393626A Application of sesquiterpene compound in mite killing drug preparation
11/20/2013CN103393625A Application of fungus polyketide in preparation of medicine used for treating alzheimer disease
11/20/2013CN103393624A Montelukast sodium membrane-shape preparation
11/20/2013CN103393623A Novel preparation
11/20/2013CN103393620A Azelnidipine capsule and preparation method thereof
11/20/2013CN103393619A Vinpocetine soft capsule, and preparation method and application thereof
11/20/2013CN103393618A Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing same
11/20/2013CN103393617A Febuxostat tablet and preparation method thereof
11/20/2013CN103393616A Tamoxifen citrate tablets
11/20/2013CN103393615A Duloxetine enteric pellet and preparation method thereof
11/20/2013CN103393614A Perospirone hydrochloride sustained release preparation and preparation method thereof
11/20/2013CN103393613A Fexofenadine hydrochloride tablet and preparation method thereof
11/20/2013CN103393612A Preparation method for enalapril maleate orally disintegrating tablets
11/20/2013CN103393611A Ivabradine hydrochloride tablet and preparation method thereof
11/20/2013CN103393610A Preparation for quickly disintegrating fatty amine polymer salt
11/20/2013CN103393609A Dexrazoxane-containing composition and preparation method thereof, and dexrazoxane freeze-drying preparation and redissolving solvent thereof
11/20/2013CN103393608A Cetilistat pellet and preparation method thereof
11/20/2013CN103393607A Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
11/20/2013CN103393606A High-encapsulation-rate wild cactus polysaccharide gelatin microspheres and preparation method thereof
11/20/2013CN103393605A Composition for chemoembolotherapy of solid tumors
11/20/2013CN103393604A Tamoxifen citrate enteric coated particles
11/20/2013CN103393603A Tamoxifen citrate particles
11/20/2013CN103393602A Berberine ultrafine-particle intestinal adhesion-type sustained-release pellet and preparation method thereof
11/20/2013CN103393600A Wettable melbemycin oxime solid disperse powder, and preparation method and applications thereof
11/20/2013CN103393598A Triptolide liposome preparation for treatment of small cell lung cancer and preparation method thereof
11/20/2013CN103393596A Metronidazole suspension and preparation method thereof
11/20/2013CN103393595A Pharmaceutical composition of edaravone
11/20/2013CN103393594A Novel aripiprazole preparation composition
11/20/2013CN103393593A Pharmaceutical composition containing ambroxol hydrochloride and fructose
11/20/2013CN103393592A Sodium azulene sulfonate gel and its preparation method and use
11/20/2013CN103393561A Traditional chinese medicine composition
11/20/2013CN103393545A Carotenoid composition useful for whitening skin
11/20/2013CN103393496A Nasolacrimal drainage system implants for drug therapy
11/20/2013CN103393489A Vagina mold containing estradiol
11/20/2013CN103393488A Vagina mold containing estriol
11/20/2013CN103393182A Health-care fruit oral liquid for pregnant women
11/20/2013CN103393097A Health food with effects of sobering and protecting liver
11/20/2013CN103393071A High-potency sweetener composition with phytosterol and compositions sweetened therewith
11/20/2013CN103393070A High-potency sweetener composition with phytosterol and compositions sweetened therewith
11/20/2013CN103393066A High-potency sweetener composition with vitamin and compositions sweetened therewith
11/20/2013CN103392962A Five-traditional Chinese medicine and three-fruit lung and yin tonifying paste and preparation method thereof
11/20/2013CN103392875A Liver-nourishing tea electuary for preventing alcohol liver
11/20/2013CN103392874A Food-grade health tea soluble granules capable of nourishing kidney
11/20/2013CN103392873A Food-grade health tea soluble granules capable of nourishing brain
11/20/2013CN103392872A Food-grade health tea soluble granules capable of improving sleep
11/20/2013CN103044450B Ceftizoxime sodium compound and preparation method and drug composition of ceftizoxime sodium compound
11/20/2013CN102961397B Pharmaceutical composition of fat emulsion injection and compound amino acid injection
11/20/2013CN102924303B Tapentadol hydrochloride crystal form C, and preparation method and application thereof
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 7860